Harry Vrieling

7PUBLICATIONS
19CO-AUTHORS
Haematological tumoursMolecular targetsPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Fluid-structure interaction and aeroacoustics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 19, 2023
Performance of a RAD51-based functional HRD test on paraffin-embedded breast cancer tissue.

Lise M van Wijk, Sylvia Vermeulen, Natalja T Ter Haar

|Dec 16, 2021
RAD51 as a functional biomarker for homologous recombination deficiency in cancer: a promising addition to the HRD toolbox?

Lise M van Wijk, Andreea B Nilas, Harry Vrieling

|Jul 02, 2021
The RAD51-FFPE Test; Calibration of a Functional Homologous Recombination Deficiency Test on Diagnostic Endometrial and Ovarian Tumor Blocks.

Lise M van Wijk, Claire J H Kramer, Sylvia Vermeulen

|May 14, 2020
Alternative mRNA splicing can attenuate the pathogenicity of presumed loss-of-function variants in BRCA2.

Romy L S Mesman, Fabienne M G R Calléja, Miguel de la Hoya

|Mar 20, 2020
Quantitative phosphoproteomics to unravel the cellular response to chemical stressors with different modes of action.

Bharath Sampadi, Alex Pines, Stephanie Munk

|Feb 13, 2020
Skipping Nonsense to Maintain Function: The Paradigm of <i>BRCA2</i> Exon 12.

Laëtitia Meulemans, Romy L S Mesman, Sandrine M Caputo

Pageof 2

Frequent Collaborators

5 joint publications

Maaike P G Vreeswijk

3 joint publications

Lise M van Wijk

2 joint publications

Romy L S Mesman

2 joint publications

Claire J H Kramer